Opko Health reported $117.54M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 158M
Acadia Pharmaceuticals ACAD:US $ 96.68M 9.23M
Acorda Therapeutics ACOR:US $ 25.44M 1.6M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Akebia Therapeutics AKBA:US $ 44.33M 498K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amarin AMRN:US 90.65M 1.72M
Ardelyx ARDX:US $ 19.34M 5.1M
Arrowhead Research ARWR:US $ 33.86M 9.27M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Coherus Biosciences CHRS:US $ 48.75M 1.3M
Emergent Biosolutions EBS:US $ 84.8M 9.4M
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Exact Sciences EXAS:US $ 401.95M 61.72M
Exelixis EXEL:US $ 102.86M 3.55M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Insmed INSM:US $ 56.75M 8.52M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Ironwood Pharmaceuticals IRWD:US $ 28.86M 175K
Laboratory Of America LH:US $ 464.1M 61.7M
Lexicon Pharmaceuticals LXRX:US 8.49M 355K
Moderna Inc MRNA:US 268M 67M
Myriad Genetics MYGN:US $ 110.6M 33.3M
Opko Health OPK:US $ 117.54M 20.68M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Quest Diagnostics DGX:US $ 416M 26M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Teva Pharmaceutical Industries TEVA:US 819M 39M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
United Therapeutics UTHR:US $ 79M 47.9M
Vanda Pharmaceuticals VNDA:US $ 40.85M 7.4M